In recent years, cancer-related genes have been analyzed as predictive indicators for cancer therapies. Among those genes, the gene product of a tumor suppressor gene p53 plays an important role in cancer therapy, because the p53 molecule induces cell cycle arrest, apoptosis and depression of DNA repair after cancer therapies such as radiation, hyperthermia and anti-cancer agents. An abnormality of the p53 gene might introduce low efficiency in their cancer therapies. Mutations of p53 are observed at a high frequency in human tumors, and are recognized in about half of all malignant tumors in human. In the both systems of a human cell culture and their transplanted tumor, the sensitivities to radiation, heat and anti-cancer agents were observed in wild-type p53 cells, but not in mutated or deleted p53 cells. In this review, we discuss the p53 activation signaling pathways through the modification of p53 molecules such as phosphorylation after radiation and/or hyperthermia treatments.
INTRODUCTION
Combinations of radiation and hyperthermia therapies have been widely adopted for interdis ciplinary cancer therapy. It is well known that ionizing radiation-induced cell killing is enhanced by hyperthermia in vitro. [1, 2] Previous studies have shown that heat treatment depresses the DNA repair of radiation-induced DNA strand breaks and thymine lesions. [3, 4] In addition, it has been reported that the activities of DNA polymerases, α and β, are sensitive to heat treatment at tem peratures higher than 40°C. [5, 6] Thus, it has been understood that the synergistic effects of hyper thermia on radiation-induced cell killing is in duced mainly through the inhibition of DNA re pair mechanisms. Moreover, another possible mechanism of radiosensitization by hyperthermia has been suggested to involve the hyperthermic instability of the Ku subunits of DNA-PK, which contribute to the repair of radiation-induced dou ble-strand breaks in DNA. [7, 8] Patients with tumors that have p53 mutations often have a worse prognosis than those with tumors that don't have wild-type p53 (wtp53). [9] For prognosis-predictive assays of cancer therapy, the genetic status of the p53 gene is the most important candidate among various cancer-re lated genes. [10] We previously reported that the radio-, heat-and chemo-sensitivities of human cultured tongue squamous cell carcinoma cells are p53-dependent, and are closely correlated with the induction of apoptosis in in vitro [11] [12] [13] and in vivo. [14] [15] [16] The interactive hyperthermic enhance ment of radiosensitivity was also observed in wtp53 cells, but not in mutated p53 (mp53) cells. [17] However, it remains unclear whether the hyperthermic enhancement of tumor growth in hibition by irradiation is p53-dependent. To clarify the problem, we described in this review whether the p53 gene products contribute to the hyper thermic enhancement of tumor growth inhibition by X-ray irradiation, using transplantable human cultured tongue squamous cell carcinoma cells with an identical genotype except for the p53 gene status, as an in vivo experimental model from the view point of p53 activation and deacti vation through the modification and degradation of p53 molecules.
p53 and the Signal Pathways
The ancestor of the mammalian p53 tumor sup pressor protein is homologous to drosophila and nematodes. [18] The gene product prevents the malignant degeneration of a normal cell. In can cer cells bearing mp53, genetic stability is lost and mutations are accumulated, and therefore, ma lignant changes in the cancer progress at a high frequency. p53-mutant and p53-deleted cells account for about 50% of total advanced cancer cells. [19] The p53 mol ecules are modified for activation by many kinds of differ ent protein kinases at different portions after cell stress [ Fig  ure 1 ]. [20] p53 regulates the transcription of the phenotypic expres sions of target genes by binding to a specific sequence. One of the p53 target genes, WAF1 (wild-type p53 activated frag ment 1) inactivates PCNA regulating DNA replication, [21] and induces p53-dependent G 1 arrest through the inhibition of cyclin/CDK activity. [22, 23] During cell cycle arrest, p53-regu lated pathways, such as gadd45 (growth arrest and DNA damage inducible 45) and p53R2 (ribonucleotide reductase small subunit 2), play an important role in the repair of dam aged DNA. [24, 25] Otherwise, DNA damage induces apoptosis by several processes of p53-regulated pathways, such as Bax (Bcl-associated X protein), [26] Fas/APO-1, [27] and PAG608. [28] In contrast, p53-regulated MDM 2 (murine double minute 2) [29] functions in the negative feedback regulation of p53 activity. [26] It is reported that these determinations of cell cycle arrest or apoptosis are divided by the modification of p53 molecules, such as phosphorylation (Figure 1) , [30] acetyla tion, [31] poly (ADP-ribosyl)ation, [32] and sumoylation [33, 34] . When the cells are stressed, Ser15/Ser20 of p53 is phospho rylated, then MDM 2 is separated from the phosphorylated p53, and finally p53 is stabilized and activated. [35] [36] [37] There after, p53 binds to the promoter of WAF1 or the p53R2 gene related to DNA repair, and induces their gene expression. When there are too many DNA lesions, however, G 1 arrest and DNA repair do not succeed. In this case, p53 is phos phorylated at Ser46, and then binds to the promoter of the p53AIP1 (p53-regulated Apoptosis-Inducing Protein 1) gene. Therefore, p53AIP1 is accumulated. Apoptosis happens in the damaged cells. [38, 39] Other p53 modifications of acetyla tion and sumoylation have also been reported. It is under stood that acetylation is performed at the C-terminal re gion of p53, and the binding capacity of p53 to specific DNA is enhanced. [40] In addition, there are several reports regard ing the sumoylation of lysine 386 in p53, which seems to activate a p53-downstream transcriptional factor. [33, 34, [41] [42] [43] In these modifications, it is thought that the structural change of p53 molecules, which bind to specific DNA se quences known as p53 CON, is brought about by many kinds of the up-stream genes. On the other hand, p53 molecules are deactivated and degradated by activated MDM2 mol ecules, which are phosphorylated at multi-sites by other protein kinases [ Figure 1 ].
Moreover, p53 is reported to bind to other proteins, such as heat shock proteins (HSPs), which are a famous stress pro tein. [44, 45] Thus, p53 regulates the fate of the cells after stresses, such as cancer therapies.
p53 Dependent Synergism after Hyperthermia and X-ray Treatment
We previously reported that radio-and heat-sensitivities of cultured human tongue squamous cell carcinoma cells are p53-dependent, and are closely correlated with the induc tion of apoptosis in vitro. [11, 12] To confirm that the hyper thermic enhancement of tumor growth inhibition by X-ray irradiation is dependent on the p53 gene status, we used two kinds of cancer cell lines carrying a different p53 gene status, wtp53 and mp53. We compared heat and X-ray in duced cell killing and apoptosis frequencies in the wtp53 cells and the mp53 cells though Bax and Caspase-3 path ways. [11, 12] We adopted mild treatments with radiation and hyperthermia for transplantation on nude mice to examine non-treated group � hyperthermia at 42°C for 20 min alone X-rays at 2 Gy alone combined treatment with X-rays at 2 Gy and hyperthermia at 42°C for 20 min. B, The rate of cells positively stained for apoptosis between SAS/neo tumors (closed column) and SAS/ mp53 tumors (open column) 72 h after treatment. In all cases, three individuals, who were blind to the source of the specimen, counted a total of 500 cells in three random fields. The error bars indicate SD.*, a highly significant difference (P < 0.01) by Student's t-test the synergistic effects on tumor growth inhibition. Tumor growth curves are shown in [ Figure 2A ].
We applied an individual treatment with hyperthermia at 42°C for 20 min or X-irradiation (2 Gy) which showed almost no effect on the growth curves of the both wtp53 and mp53 tumors in the non-treated control groups [ Figure 2A ]. When the tumors were treated with a combination of X-rays and hyperthermia, the apparent enhancement of tumor growth inhibition was observed in the wtp53 tumors, but not the mp53 tumors.
We examined both the accumulation of apoptosis-related proteins and the incidence of apoptosis by immunohisto chemical analysis [ Figure 2B ]. The apoptosis incidence was apparently higher in the wtp53 tumors 72 h after the com bined treatment, but not in the mp53 tumors. The fragmen tation of PARP and Caspase-3 as the activation of Caspase 3 showed almost the same pattern as the incidence of apoptosis in the wtp53 tumor. [46] p53 Gene Status as a Predictive Indicator in Cancer Therapy
As previously reported, if the hyperthermic enhancement of radiosensitivity results in heat-induced denaturation of repair enzymes for DNA damage, the synergism of the com bination therapy of radiation and hyperthermia should be similarly detected in both wtp53 and mp53 tumors. How ever, it is very interesting that the synergistic depression of tumor growth was found only in the wtp53 tumors 46) . These findings suggest that the hyperthermic enhance ment of tumor growth inhibition by irradiation may result in p53-dependent apoptosis due to heat-induced inactiva tion of the cell survival system (s), through either regula tion of the cell cycle or induction of DNA repair. Thus, mp53 tumors may rarely include this function, which promotes cell killing by the heat-induced interactive inactivation of the repair enzyme (s) for certain types of sublethal dam age. As participants in the p53-dependent apoptotic proc esses, the induction of apoptosis mediated by caspase-3 activation was examined in these tumors. In fact, activated Caspase-3 was confirmed from the proteolysis of several important molecules, such as PARP and Caspase-3 itself so called markers of apoptosis. [47, 48] The induction of p53-de pendent apoptosis showed a pattern similar to the tumor growth inhibition after combined treatments with radia tion and hyperthermia [ Figure 3] . Therefore, gene analysis of the p53 gene status of cancer cells can be used as a pre dictive assay for the effectiveness of combined therapy with radiation and hyperthermia [ Figure 3 ].
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